Sumitomo Dainippon (Germany) Profile

EUR 0.48  2.66%

Sumitomo Dainippon Summary

Sumitomo Dainippon Pharma Co Ltd (DPM) is traded on Frankfurt Stock Exchange in Germany. It is located in 6-8 Doshomachi 2-chome and employs 6,492 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.85 B. Sumitomo Dainippon Pharma Co Ltd has 397.3 M outstanding shares. DAINIP S'TOMO PHA has accumulated about 1.28 B in cash with 476.38 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22.
Check Sumitomo Dainippon Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 18.55HorizonTargetOdds Above 18.55
?%30 days 18.55 ?%
Based on normal probability distribution, the odds of Sumitomo Dainippon to move above current price in 30 days from now is about 0.0% (This Sumitomo Dainippon Pharma Co Ltd probability density function shows the probability of Sumitomo Dainippon Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

Sumitomo Dainippon Against Markets

Current Ratings

Sumitomo Dainippon 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Sumitomo Dainippon Pharma Co Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients, food additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Sumitomo Dainippon operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6492 people. more
NameSumitomo Dainippon Pharma Co Ltd
CEOJonathan GoodmanView All
Macroaxis Advice
InstrumentGermany Stock View All
Business Address6-8 Doshomachi 2-chome
Foreign Associate  USA
ExchangeFrankfurt Stock Exchange
Contact Number81 6 6203 5321
CurrencyEUR - Euro

Current Sentiment - DPM

Sumitomo Dainippon P Investor Sentiment
Macroaxis portfolio users are insensible in their opinion about investing in Sumitomo Dainippon Pharma Co Ltd. What is your outlook on investing in Sumitomo Dainippon Pharma Co Ltd? Are you bullish or bearish?
50% Bullish
50% Bearish

Diversify with Sumitomo Dainippon Pharma Co Ltd

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Sumitomo Dainippon Pharma Co Ltd to your portfolio


Sumitomo Dainippon Corporate Directors
Peter Nixon Independent Director
Peter Gillin Lead Independent Director
MarieAnne Tawil Director, MBA
Additionally see Investing Opportunities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.